Catalog No.:AA024BLG

1361390-56-8 | (5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate

Name: Name:(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate
Brand: AABLOCKS
SKU: AA024BLG
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

25mg

97%

1 week

$324.00 $227.00

- +

50mg

97%

1 week

$549.00 $385.00

- +

100mg

97%

1 week

$931.00 $652.00

- +

250mg

97%

1 week

$1,582.00 $1,107.00

- +

97%

1 week

$4,266.00 $2,987.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA024BLG

Chemical Name:

(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate

CAS Number:

1361390-56-8

Molecular Formula:

C24H28N6O10

Molecular Weight:

560.5133

MDL Number:

MFCD31657423

SMILES:

O=C(N[C@H](C(=O)N[C@H](C(=O)NN(C(=O)/C=C/C(=O)ON1C(=O)CCC1=O)CC(=O)N)C)C)OCc1ccccc1

Properties

Literature

Title: Liao D, et al. Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine. 2011 Dec;7(6):665-73.

Title: Ralph A, et al. Nanoparticle-based tumor-targeted drug delivery. Patent: CA2809617C

Title: Yang H, et al. Legumain is a predictor of all-cause mortality and potential therapeutic target in acute myocardial infarction. Cell Death Dis. 2020;11(11):1014. Published 2020 Nov 26.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS